Company Filing History:
Years Active: 2015
Title: Ha Na Woo - Innovator in Anticancer Formulations
Introduction
Ha Na Woo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the solubility of therapeutic agents to improve their efficacy in cancer treatment.
Latest Patents
Ha Na Woo holds a patent for a polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility. This invention specifically addresses the challenges associated with the low water solubility of rapamycin. The formulation enhances the delivery of rapamycin, making it more effective when used in combination with radiotherapy. The patent outlines the preparation method of this formulation and its application in anticancer therapies.
Career Highlights
Ha Na Woo is associated with Samyang Biopharmaceuticals Corporation, where he continues to advance his research in drug formulation. His innovative approach has positioned him as a key figure in the biopharmaceutical industry, contributing to the development of effective cancer treatments.
Collaborations
Ha Na Woo collaborates with talented colleagues, including Hye Won Kang and Min Hyo Seo. Their combined expertise fosters a dynamic research environment that drives innovation in biopharmaceuticals.
Conclusion
Ha Na Woo's contributions to the field of biopharmaceuticals, particularly through his patent on improved rapamycin formulations, highlight his role as an innovator in cancer treatment. His work continues to pave the way for advancements in therapeutic applications.